Top Markets
Coin of the day
Cardax, Inc. Cardax, Inc.

Cardax, Inc.

CDXI
Ранг среди акций #42795
Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and... Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and marketing nutritional supplements for maintaining inflammatory well-being, as well as developing pharmaceutical treatments for chronic ailments rooted in inflammation and oxidative stress. Its product portfolio includes ZanthoSyn, an advanced supplement for inflammation, health, and longevity that delivers astaxanthin with superior absorption and purity. This product is primarily distributed through online sales and wholesale channels. The company is also progressing two pharmaceutical candidates: CDX-101, an astaxanthin-derived drug candidate intended to address cardiovascular inflammation and dyslipidemia, with a primary focus on severe hypertriglyceridemia; and CDX-301, a zeaxanthin-based pharmaceutical currently under development for macular degeneration. Cardax, Inc. maintains its headquarters in Honolulu, Hawaii.
Цена акции
$0.0001
Последняя синхронизация: 2026-08-11
Рыночная капитализация
$80.00
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Cardax, Inc. (CDXI)

Категория

EPS для Cardax, Inc. (CDXI)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Cardax, Inc., текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Cardax, Inc. с 2026 по 2026
EPS на конец каждого года
Год EPS Изменить
Недостаточно данных для указанных дат.
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$17.32 -
US
$27.74 -
NL
- -
CH
$13.70 -
BE
- -
KR